Get the Stockscreener App
9.98
1.48%
-0.15
After Hours:
9.98
Dynavax Technologies Corp stock is traded at $9.98, with a volume of 1.83M.
It is down -1.48% in the last 24 hours and down -10.41% over the past month.
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
See More
Previous Close:
$10.13
Open:
$10.16
24h Volume:
1.83M
Relative Volume:
1.10
Market Cap:
$1.17B
Revenue:
$260.81M
Net Income/Loss:
$20.48M
P/E Ratio:
76.77
EPS:
0.13
Net Cash Flow:
$22.67M
1W Performance:
-2.82%
1M Performance:
-10.41%
6M Performance:
-28.10%
1Y Performance:
-8.10%
1-Day Range:
$9.90
$10.28
1-Week Range:
$9.77
$10.30
52-Week Range:
$9.22
$14.63
Dynavax Technologies Corp Stock (DVAX) Company Profile
Name
Dynavax Technologies Corp
Sector
Phone
(510) 848-5100
Address
2100 POWELL STREET, EMERYVILLE, CA
Compare DVAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVAX
Dynavax Technologies Corp
|
9.98 | 1.16B | 260.81M | 20.48M | 22.67M | 0.13 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Downgrade | Goldman | Neutral → Sell |
| Feb-01-24 | Initiated | Goldman | Neutral |
| Sep-27-22 | Initiated | JMP Securities | Mkt Outperform |
| Jan-06-22 | Resumed | Goldman | Buy |
| Aug-06-21 | Initiated | Goldman | Buy |
| Aug-07-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-03-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-15-20 | Initiated | Evercore ISI | Outperform |
| Oct-18-19 | Initiated | H.C. Wainwright | Buy |
| Jul-11-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-27-19 | Reiterated | Cantor Fitzgerald | Overweight |
| May-10-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-08-18 | Reiterated | Cantor Fitzgerald | Overweight |
| Feb-14-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-25-17 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-15-17 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-31-17 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-31-17 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Apr-28-16 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Apr-27-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Initiated | RBC Capital Mkts | Outperform |
| Nov-25-13 | Upgrade | MLV & Co | Hold → Buy |
| Feb-25-13 | Downgrade | MLV & Co | Buy → Hold |
| Nov-16-12 | Reiterated | MLV & Co | Buy |
View All
Dynavax Technologies Corp Stock (DVAX) Latest News
Applying sector rotation models to Dynavax Technologies CorporationJuly 2025 Market Mood & Real-Time Chart Pattern Alerts - Newser
Top chart patterns to watch in Dynavax Technologies CorporationJuly 2025 Review & Risk Controlled Swing Trade Alerts - Newser
Can machine learning forecast Dynavax Technologies Corporation recoveryMarket Trend Summary & Daily Momentum Trading Reports - Newser
Applying Wyckoff theory to Dynavax Technologies Corporation stockMarket Performance Report & Free Fast Entry Momentum Trade Alerts - Newser
What the charts say about Dynavax Technologies Corporation today2025 Winners & Losers & Real-Time Volume Trigger Notifications - Newser
Multi asset correlation models including Dynavax Technologies CorporationJuly 2025 Intraday Action & Daily Entry Point Alerts - Newser
Intraday pattern recognizer results for Dynavax Technologies CorporationJuly 2025 EndofMonth & Free Growth Oriented Trading Recommendations - Newser
Is Dynavax Technologies Corporation stock entering bullish territoryMarket Weekly Review & Low Volatility Stock Suggestions - Newser
Price action breakdown for Dynavax Technologies CorporationExit Point & AI Driven Stock Movement Reports - Newser
Dynavax Technologies Corporation stock trendline breakdownQuarterly Profit Review & Community Verified Watchlist Alerts - Newser
Visual trend scoring systems applied to Dynavax Technologies CorporationMarket Trend Report & High Return Trade Guides - Newser
Wellington Management Group LLP Has $736,000 Holdings in Dynavax Technologies Corporation $DVAX - Defense World
Northern Trust Corp Cuts Stock Holdings in Dynavax Technologies Corporation $DVAX - Defense World
HighTower Advisors LLC Has $365,000 Position in Dynavax Technologies Corporation $DVAX - Defense World
Dynavax Technologies Corporation (DVAX) Reports Record $92M HEPLISAV-B Revenue, Raises 2025 Outlook - Insider Monkey
Dynavax’s SWOT analysis: vaccine maker’s stock poised for growth amid challenges - Investing.com
Visual analytics tools that track Dynavax Technologies Corporation performanceWeekly Trade Summary & Community Consensus Picks - Newser
What recovery options are there for Dynavax Technologies CorporationWeekly Trend Summary & Community Supported Trade Ideas - Newser
Dynavax Technologies Corporation stock volume spike explainedPortfolio Update Report & Long-Term Safe Investment Plans - Newser
Signal strength of Dynavax Technologies Corporation stock in tech scannersPortfolio Value Report & Verified Short-Term Trading Plans - Newser
Using Python tools to backtest Dynavax Technologies Corporation strategiesJuly 2025 Closing Moves & Technical Pattern Based Buy Signals - Newser
When is the best time to exit Dynavax Technologies CorporationJuly 2025 Gainers & Technical Pattern Based Buy Signals - Newser
Will Dynavax Technologies Corporation benefit from macro trendsMarket Trend Review & Free Real-Time Volume Trigger Notifications - Newser
Dynavax Technologies Corporation stock retracement – recovery analysisTrade Analysis Report & Expert-Curated Trade Recommendations - Newser
What data driven models say about Dynavax Technologies Corporation’s futureMarket Sentiment Report & AI Forecast Swing Trade Picks - Newser
Pattern recognition hints at Dynavax Technologies Corporation upsideTrade Signal Summary & Safe Capital Allocation Plans - Newser
What earnings revisions data tells us about Dynavax Technologies CorporationMarket Volume Report & Weekly Chart Analysis and Trade Guides - Newser
Has Dynavax Technologies Corporation formed a bullish divergenceWeekly Gains Summary & Scalable Portfolio Growth Methods - Newser
Analyzing drawdowns of Dynavax Technologies Corporation with statistical toolsRecession Risk & Consistent Growth Stock Picks - Newser
Statistical indicators supporting Dynavax Technologies Corporation’s strength2025 Sector Review & Real-Time Buy Signal Notifications - Newser
Dynavax Technologies Corp Stock (DVAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Dynavax Technologies Corp Stock (DVAX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Deep Track Biotechnology Maste | 10% Owner |
Aug 21 '25 |
Sale |
11.03 |
1,094,994 |
12,077,784 |
16,696,492 |
| Deep Track Biotechnology Maste | 10% Owner |
Aug 22 '25 |
Sale |
10.59 |
970,143 |
10,273,814 |
15,726,349 |
| Novack David F | President & COO |
Mar 24 '25 |
Option Exercise |
6.80 |
10,000 |
68,050 |
18,078 |
| Novack David F | President & COO |
Mar 24 '25 |
Sale |
14.00 |
10,000 |
140,000 |
8,078 |
3.60%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):